EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Use of Imaging and Biopsy in Prostate Cancer Diagnosis: A Survey From the Asian Prostate Imaging Working Group

Li-Jen Wang iD, Masahiro Jinzaki iD, Cher Heng Tan iD, Young Taik Oh iD, Hiroshi Shinmoto iD, Chau Hung Lee iD, Nayana U Patel iD, Silvia D Chang iD, Antonio C Westphalen iD, Chan Kyo Kim iD

Korean Journal of Radiology · 2023

DOI: 10.3348/kjr.2023.0644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Korean Journal of Radiology, 2023. Verfasst von Li-Jen Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging and Intervention, New Taipei Municipal Tucheng Hospital, Chang Gung Medical Foundation, New Taipei, Taiwan. Hauptthemen laut MEDLINE: Prostate, Prostatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To elucidate the use of radiological studies, including nuclear medicine, and biopsy for the diagnosis and staging of prostate cancer (PCA) in clinical practice and understand the current status of PCA in Asian countries via an international survey. MATERIALS AND METHODS: The Asian Prostate Imaging Working Group designed a survey questionnaire with four domains focused on prostate magnetic resonance imaging (MRI), other prostate imaging, prostate biopsy, and PCA backgrounds. The questionnaire was sent to 111 members of professional affiliations in Korea, Japan, Singapore, and Taiwan who were representatives of their working hospitals, and their responses were analyzed. RESULTS: This survey had a response rate of 97.3% (108/111). The rates of using 3T scanners, antispasmodic agents, laxative drugs, and prostate imaging-reporting and data system reporting for prostate MRI were 21.6%-78.9%, 22.2%-84.2%, 2.3%-26.3%, and 59.5%-100%, respectively. Respondents reported using the highest b-values of 800-2000 sec/mm² and fields of view of 9-30 cm. The prostate MRI examinations per month ranged from 1 to 600, and they were most commonly indicated for biopsy-naïve patients suspected of PCA in Japan and Singapore and staging of proven PCA in Korea and Taiwan. The most commonly used radiotracers for prostate positron emission tomography are prostate-specific membrane antigen in Singapore and fluorodeoxyglucose in three other countries. The most common timing for prostate MRI was before biopsy (29.9%). Prostate-targeted biopsies were performed in 63.8% of hospitals, usually by MRI-ultrasound fusion approach. The most common presentation was localized PCA in all four countries, and it was usually treated with radical prostatectomy. CONCLUSION: This survey showed the diverse technical details and the availability of imaging and biopsy in the evaluation of PCA. This suggests the need for an educational program for Asian radiologists to promote standardized evidence-based imaging approaches for the diagnosis and staging of PCA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstateProstatic NeoplasmsMaleHumansProstate-Specific AntigenImage-Guided BiopsyBiopsyMagnetic Resonance ImagingPositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

BiopsyMagnetic resonance imagingPETPSMAProstate cancerReportSurvey

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Medical Imaging and Intervention, New Taipei Municipal Tucheng Hospital, Chang Gung Medical Foundation, New Taipei, Taiwan.
  • Department of Medical Imaging and Intervention, Linkou Chang Gung Medical Hospital, Taoyuan, Taiwan.
  • Department of Medical Imaging and Radiological Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Department of Radiology, Keio University, School of Medicine, Tokyo, Japan.
  • Department of Diagnostic Radiology, Tan Tock Seng Hospital, National Health Care Group, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

ORCID-Profile: Li-Jen Wang, Masahiro Jinzaki, Cher Heng Tan, Young Taik Oh, Hiroshi Shinmoto, Chau Hung Lee, Nayana U Patel, Silvia D Chang, Antonio C Westphalen, Chan Kyo Kim

Zitieren

APA

Wang, L. J., Jinzaki, M., Tan, C. H., Oh, Y. T., Shinmoto, H., Lee, C. H., Patel, N. U., Chang, S. D., Westphalen, A. C., & Kim, C. K. (2023). Use of Imaging and Biopsy in Prostate Cancer Diagnosis: A Survey From the Asian Prostate Imaging Working Group. Korean Journal of Radiology. https://doi.org/10.3348/kjr.2023.0644

Vancouver

Wang LJ, Jinzaki M, Tan CH, Oh YT, Shinmoto H, Lee CH, et al. Use of Imaging and Biopsy in Prostate Cancer Diagnosis: A Survey From the Asian Prostate Imaging Working Group. Korean Journal of Radiology. 2023. doi:10.3348/kjr.2023.0644

BibTeX
@article{Wang2023,
  author = {Wang, Li-Jen and Jinzaki, Masahiro and Tan, Cher Heng and Oh, Young Taik and Shinmoto, Hiroshi and Lee, Chau Hung and Patel, Nayana U and Chang, Silvia D and Westphalen, Antonio C and Kim, Chan Kyo},
  title = {Use of Imaging and Biopsy in Prostate Cancer Diagnosis: A Survey From the Asian Prostate Imaging Working Group},
  journal = {Korean Journal of Radiology},
  year = {2023},
  doi = {10.3348/kjr.2023.0644}
}
Kostenlos starten →